Leading
Pharma Innovation
Explore Our Core Competencies
Science of Quality & Prediction
Advanced Formulations
Next-Generation Manufacturing
Flow Chemistry
RCPE accelerates pharmaceutical progress
The Research Center Pharmaceutical Engineering (RCPE) is a globally recognized, independent and not-for-profit research company at the forefront of pharmaceutical process and product development. We deliver innovative, tailor-made solutions for the pharmaceutical industry – covering everything from sophisticated in silico prediction and formulation to upscaling in our state-of-the-art pilot plant. Our interdisciplinary team combines scientific and engineering expertise to accelerate the development and manufacturing of tomorrow’s medicines and improve the lives of patients worldwide.
News and Press
- Media
Emergency Pharmaceutical Production in Times of Crisis
20.11.2025 | militär AKTUELL | In an interview with Militär AKTUELL, Dr. Caroline Schober, Chief Strategy Development and Communications Officer at RCPE GmbH, explains the concept of emergency pharmaceutical production and the role played by policymakers and the Austrian Armed Forces.
- Media
Drug Shortages in Austria
28.11.2025 | Wirtschaftsnachrichten | How dependent is Austria on Asia for pharmaceuticals? RCPE Graz offers solutions for strategic supply security and emergency production in the event of supply chain disruptions. What matters more – economic viability or human lives?
- Media
Building Resilience in Times of Crisis
20.11.2025 | JUST Magazin | Ensuring the supply of medicines is an underestimated pillar of national resilience. Innovative research and coordinated emergency production strengthen Austria’s defense capability and demonstrate how military thinking and logistics can serve as a model for civilian security.
- News
Consortium Meeting of the COMET Module Twin4Pharma
22.10.2025 | Last week, the Twin4Pharma consortium meeting took place, offering exciting insights and lively discussions between science and industry. Together, we are working to make data-driven sustainability a reality in the pharmaceutical industry.
Events und Veranstaltungen
- 9-11
- Nov
AAPS PharmSci 360
RCPE scientists present their latest research findings at AAPS, offering exciting insights into continuous manufacturing and advanced drug delivery technologies. Visit us at booth no. 3428 to learn how RCPE is driving innovation in pharmaceutical process development.
Our Shareholders
RCPE’s ownership structure is unique: we are a private, non-profit company jointly owned by Graz University of Technology (49%), the University of Graz (36%), and the non-university, public research organization Joanneum Research GmbH (15%). This ensures our complete independence from the pharmaceutical industry and positions us as a neutral, publicly owned research organization.
Our Public Funding Partners
RCPE is funded under the K1 COMET Program (Competence Centers for Excellent Technologies), an Austrian flagship initiative designed to promote outstanding, application-oriented research and development in key technology areas. The COMET Program is jointly funded by the Austrian federal government, the federal states, participating companies, and research organizations.
